- A new orodispersible film formulation of nicotine (Niquitin Strips) has been launched by GSK as an aid to smoking cessation or reduction.
- The influenza vaccines Agrippal and Optaflu (both Novartis) are now available for the 2013/2014 flu season.
- Zonegran (zonisamide) is now licensed for use as adjunctive therapy for partial seizures with or without secondary generalisation in children aged six years and older.
- The TNF-alpha inhibitor Simponi (golimumab) can now be used to treat moderate to severe ulcerative colitis when conventional treatments, including corticosteroids, 6-mercaptopurine and azathioprine, are unsuitable.
- The MHRA has restricted the use of short-acting β2-agonists in obstetric indications to parenteral preparations, with a maximum treatment period of 48 hours and a requirement for specialist supervision. This is due to the risk of serious cardiovascular events in the mother and the foetus/newborn.
- Revolade (eltrombopag) can now be prescribed for patients with chronic hepatitis C where thrombocytopenia prevents or limits optimal interferon-based therapy.
- Zedbac is the first parenteral formulation of the antibacterial azithromycin to be launched in the UK and is licensed for use in community-acquired pneumonia and pelvic inflammatory disease when initial intravenous treatment is required.
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
Register or Subscribe to MIMSGPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.
MIMS bulletinsNews and updates straight to your inbox.
Prescribing Update: Fortnightly news bulletin
Alert: Urgent prescribing updates
Spotlight: Disease-themed monthly round-up
Read the latest issue online exclusively on MIMS Learning.
Handy calculators and conversions for primary care.